Eric H Yang, Director of the UCLA Cardio-Oncology Program, shared a post on X about a recent article he and his colleagues co-authored, adding:
“Fantastic Cardio-Oncology review led by Department of Medicine at UCLA Health IM res on mechanisms of ICI and ACS in Journal of the American Heart Association issue on the intersection of inflammation
CVD As ICI use in cancer, we mechanisms of its impact on ASCVD and cancer survivorship.”
Title: Immune Checkpoint Inhibitor Therapy and Acute Coronary Syndrome: A Review of Mechanisms and Management
Authors: Rachel S. Saganty, Orly Leiva, Elizabeth Hutchins, Ashley F. Stein-Merlob, Eric H. Yang
Read the Full Article on Journal of the American Heart Association
More posts featuring Eric H Yang.
